MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0017008
Bsure Pharmaceuticals Private Limited
Bsure Pharmaceuticals Private Limited - pharma in Patna, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.26 Cr
▲ 54% YoY
Net profit · FY 2025
₹12.06 Lakh
Net margin 5.3%
EBITDA · FY 2025
₹18.6 Lakh
EBITDA margin 8.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Satisfied ₹2 Lakh
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Bsure Pharmaceuticals Private Limited
Data last updated:
Bsure Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51101BR2014PTC022046. Its GSTIN is 10AAFCB8851L1ZL (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anshuman Singh and Ankit Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Raghuraj Complex Rupas Colony Kumhrar, Patna, Bihar, India – 800026.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹12.06 Lakh (net margin 5.3%) and EBITDA of ₹18.6 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 78% over five years.
As per MCA filings, the company has open charges of ₹75 Lakh and satisfied charges of ₹2 Lakh on record.
Bsure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0017008). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51101BR2014PTC022046
Registration Number 022046
Incorporation Date 13 February 2014
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0017008
Key People
Anshuman Singh Director Ankit Singh Director Recognitions & Rankings of Bsure Pharmaceuticals
Contact details
Bsure Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRaghuraj Complex Rupas Colony Kumhrar, Patna, Bihar, India – 800026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bsure Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bsure Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bsure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bsure Pharmaceuticals Private Limited, buy the company report.
Financials of Bsure Pharmaceuticals Private Limited
FY 2024 filings availableBsure Pharmaceuticals Private Limited reported revenue of ₹2.26 Cr (up 54% YoY) for FY 2025.
Revenue · FY 2025
₹2.26 Cr ▲ 54%
Net profit · FY 2025
₹12.06 Lakh margin 5.3%
EBITDA · FY 2025
₹18.6 Lakh margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 79%
5 years · compounded
▲ 78%
EBITDA CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 78%
5 years · compounded
▲ 84%
Revenue has grown at a compounded annual rate (CAGR) of 78% over five years, including 54% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bsure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bsure Pharmaceuticals Private Limited
Bsure Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshuman Singh | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
| Ankit Singh Also directs: Consulto Indico Private Limited | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
Bsure Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avant Remedies Private Limited | ₹2.26 Cr (FY 2023) | 30.0% | Indore, Madhya Pradesh, India | |||
| Bsure Pharmaceuticals Private Limitedthis company | ₹2.26 Cr (FY 2025) | ₹12.06 Lakh | 5.3% | 54.0% | Patna, Bihar, India | |
| Likameda Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Auster Lifescience India Private Limited | ₹2.26 Cr (FY 2023) | -19.0% | Thrissur, Kerala, India | |||
| Mediex Healthcare Private Limited | ₹2.25 Cr (FY 2023) | 44.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Bsure Pharmaceuticals Private Limited, buy the company report.
Auditor
Bsure Pharmaceuticals Private Limited is audited by B R K & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B R K & CO. | FY 2023 | 025078C |
Shareholding
The shareholding of Bsure Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bsure Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹75 Lakh
Satisfied charges
₹2 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jun 2022 | 100585064 | Bank of India | ₹70 Lakh | Open | |
| 26 Apr 2021 | 100448882 | Bank of India | ₹5 Lakh | Open | |
| 27 Feb 2019 | 100256880 | Others | ₹2 Lakh | Satisfied |
To see the full charge records of Bsure Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Bsure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bsure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bsure Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCB8851L1ZL | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bsure Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bsure Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Ankit Singh was appointed as Director on 13 Feb 2014.
Charges
A charge with Bank Of India of Rs. 70.00 Lakh registered on 03 Jun 2022 with Charge ID 100585064 was modified on 19 Nov 2025.
AGM
Bsure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Bsure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.
Charges
A charge with Bank Of India amounted to Rs. 70.00 Lakh with Charge ID 100585064 was registered on 03 Jun 2022.
Charges
A charge with Bank Of India amounted to Rs. 5.00 Lakh with Charge ID 100448882 was registered on 26 Apr 2021.
Charges
A charge registered on 27 Feb 2019 via Charge ID 100256880 with Others was fully satisfied on 16 Apr 2021.
Charges
A charge with Others amounted to Rs. 2.00 Lakh with Charge ID 100256880 was registered on 27 Feb 2019.
Appointed
Ankit Singh was appointed as Director.
Appointed
Anshuman Singh was appointed as Director.
Incorporation
13 Feb 2014
Bsure Pharmaceuticals Private Limited was registered on 13 Feb 2014 with Roc Patna & aged 12 years 8 months as per MCA records.
Frequently asked questions
Bsure Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U51101BR2014PTC022046.
Bsure Pharmaceuticals has 2 current directors:
- Anshuman Singh - Director
- Ankit Singh - Director
The latest financial statements of Bsure Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Bsure Pharmaceuticals is 10AAFCB8851L1ZL, registered in Bihar.
The CIN (Corporate Identification Number) of Bsure Pharmaceuticals is U51101BR2014PTC022046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bsure Pharmaceuticals was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Bsure Pharmaceuticals by revenue are Avant Remedies Private Limited, Likameda Pharmaceuticals Private Limited, Auster Lifescience India Private Limited, Mediex Healthcare Private Limited, all in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services), with the same principal business activity (wholesale trading).
Ankit Singh was appointed as Director on 13 Feb 2014. Anshuman Singh was appointed as Director on 13 Feb 2014.
Yes, Bsure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0017008).
The registered office of Bsure Pharmaceuticals is at Raghuraj Complex Rupas Colony Kumhrar, Patna, Bihar, India – 800026.
Bsure Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.